Nano-X Imaging Ltd.(NNOX)Earnings, Financials & Key Ratios
NNOX•NASDAQ
Price updated Jun 19, 2026
AboutNano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.Show more
- Revenue$11M+13.9%
- EBITDA-$45M+11.4%
- Net Income-$54M+11.9%
- EPS (Diluted)-0.91+15.7%
- Gross Margin-94.03%-41.3%
- EBITDA Margin-398.95%+22.2%
- Operating Margin-502.93%+20.4%
- Net Margin-474.31%+22.7%
- ROE-27.83%+3.8%
NNOX Key Insights
Nano-X Imaging Ltd. (NNOX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.5x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 8 (bottom 8%)
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NNOX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NNOX Price & Volume
Nano-X Imaging Ltd. (NNOX) stock price & volume — 10-year historical chart
Loading chart...
NNOX Growth Metrics
Nano-X Imaging Ltd. (NNOX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years105.3%
TTM15.19%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-12.08%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-3.53%
Return on Capital
10 Years-31.81%
5 Years-31.81%
3 Years-32.33%
Last Year-28.43%
NNOX Recent Earnings
Nano-X Imaging Ltd. (NNOX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (27%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
Apr 20, 2026Metric
Actual
Est
EPS
$0.50-117.4%
$0.23
Rev
$4M-12.5%
$4M
Q4 2025
Nov 20, 2025Metric
Actual
Est
EPS
$0.65-333.3%
$0.15
Rev
$3M-13.7%
$4M
Q3 2025
Aug 12, 2025Metric
Actual
Est
EPS
$0.23-31.4%
$0.17
Rev
$3M-13.3%
$4M
Q2 2025
May 22, 2025Metric
Actual
Est
EPS
$0.21-10.5%
$0.19
Rev
$3M-17.2%
$3M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 20, 2026 | $0.50vs $0.23-117.4% | $4Mvs $4M-12.5% |
| Q4 2025 | Nov 20, 2025 | $0.65vs $0.15-333.3% | $3Mvs $4M-13.7% |
| Q3 2025 | Aug 12, 2025 | $0.23vs $0.17-31.4% | $3Mvs $4M-13.3% |
| Q2 2025 | May 22, 2025 | $0.21vs $0.19-10.5% | $3Mvs $3M-17.2% |
Based on last 12 quarters of dataView full earnings history →
NNOX Peer Comparison
Nano-X Imaging Ltd. (NNOX) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HOLO | 2.55M | 1.75 | -0.27 | 42.62% | 91.92% | 10.3% | 0.00 | |
 ATEC | 1.33B | 8.81 | -9.18 | 24.95% | -21.07% | -443.09% | 17.21 | |
 PRCT | 1.24B | 21.72 | -12.63 | 37.22% | -31.82% | -27.7% | 0.14 | |
 GEHC | 28.02B | 61.59 | 13.54 | 4.84% | 7.54% | 14.45% | 0.94 | |
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 | |
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 |
Compare NNOX vs Peers
Nano-X Imaging Ltd. (NNOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NNOX Income Statement
Nano-X Imaging Ltd. (NNOX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 1.3M | 8.58M | 9.9M | 11.28M | 12.3M |
Revenue Growth % | - | - | - | - | 557.82% | 15.47% | 13.91% | 15.19% |
Cost of Goods Sold | 35K | 53K | 208K | 2.82M | 15.46M | 16.5M | 21.89M | 24.46M |
COGS % of Revenue | - | - | - | 215.95% | 180.21% | 166.55% | 194.03% | - |
Gross Profit | -35K▲ 0% | -53K▼ 51.4% | -208K▼ 292.5% | -1.51M▼ 626.9% | -6.88M▼ 355.0% | -6.59M▲ 4.2% | -10.61M▼ 60.9% | -12.16M▲ 0% |
Gross Margin % | - | - | - | -115.95% | -80.21% | -66.55% | -94.03% | -98.83% |
Gross Profit Growth % | - | -51.43% | -292.45% | -626.92% | -355.03% | 4.19% | -60.94% | - |
Operating Expenses | 1.9M | 22.57M | 43.92M | 60.05M | 72.33M | 56M | 46.14M | 45.63M |
OpEx % of Revenue | - | - | - | 4604.75% | 843.18% | 565.34% | 408.91% | - |
Selling, General & Admin | 1.23M | 19.85M | 34.71M | 41.74M | 45.63M | 28.39M | 25.75M | 25.67M |
SG&A % of Revenue | - | - | - | 3201.07% | 531.94% | 286.66% | 228.21% | - |
Research & Development | 672K | 2.72M | 9.21M | 17.12M | 26.51M | 26.05M | 20.18M | 19.8M |
R&D % of Revenue | - | - | - | 1313.04% | 309.01% | 262.99% | 178.87% | - |
Other Operating Expenses | 0 | 0 | 0 | 1.18M | 191K | 1.55M | 206K | 162K |
Operating Income | -1.9M▲ 0% | -22.57M▼ 1085.5% | -43.92M▼ 94.6% | -61.56M▼ 40.1% | -109.71M▼ 78.2% | -62.59M▲ 43.0% | -56.75M▲ 9.3% | -57.79M▲ 0% |
Operating Margin % | - | - | - | -4720.71% | -1278.97% | -631.89% | -502.93% | -469.74% |
Operating Income Growth % | - | -1085.45% | -94.6% | -40.15% | -78.22% | 42.95% | 9.34% | - |
EBITDA | -1.87M | -22.52M | -43.72M | -59.27M | -98.2M | -50.78M | -45.01M | -46M |
EBITDA Margin % | - | - | - | -4544.94% | -1144.77% | -512.66% | -398.95% | -373.95% |
EBITDA Growth % | - | -1104.82% | -94.13% | -35.57% | -65.69% | 48.29% | 11.36% | -6.52% |
D&A (Non-Cash Add-back) | 35K | 53K | 208K | 2.29M | 11.51M | 11.81M | 11.73M | 11.79M |
EBIT | -1.9M | -22.57M | -43.81M | -61.56M | -87.21M | -59.66M | -56.75M | -56.51M |
Net Interest Income | 0 | 8K | 108K | -288K | 789K | 1.65M | 2.87M | 1.89M |
Interest Income | 0 | 8K | 108K | 0 | 789K | 1.65M | 2.87M | 2.04M |
Interest Expense | 5K | 0 | 0 | 288K | 0 | 0 | 0 | 149K |
Other Income/Expense | -5K | 8K | 108K | -288K | -14.67M | 1.47M | 2.87M | 1.89M |
Pretax Income | -1.91M▲ 0% | -22.56M▼ 1081.9% | -43.81M▼ 94.2% | -61.85M▼ 41.2% | -108.92M▼ 76.1% | -61.12M▲ 43.9% | -53.87M▲ 11.8% | -55.9M▲ 0% |
Pretax Margin % | - | - | - | -4742.79% | -1269.77% | -617.01% | -477.48% | -454.38% |
Income Tax | 5K | 0 | 0 | -48K | -3.68M | -339K | -358K | -192K |
Effective Tax Rate % | -0.26% | 0% | 0% | 0.08% | 3.38% | 0.55% | 0.66% | 0.34% |
Net Income | -1.91M▲ 0% | -22.55M▼ 1081.5% | -43.5M▼ 92.9% | -61.8M▼ 42.1% | -105.24M▼ 70.3% | -60.78M▲ 42.3% | -53.52M▲ 11.9% | -55.71M▲ 0% |
Net Margin % | - | - | - | -4739.11% | -1226.89% | -613.59% | -474.31% | -452.82% |
Net Income Growth % | - | -1081.51% | -92.86% | -42.07% | -70.3% | 42.25% | 11.95% | -12.08% |
Net Income (Continuing) | -1.91M | -22.56M | -43.81M | -61.8M | -113.24M | -60.78M | -53.52M | -55.71M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.06▲ 0% | -0.49▼ 776.6% | -1.22▼ 149.0% | -1.28▼ 4.9% | -2.01▼ 57.0% | -1.08▲ 46.3% | -0.91▲ 15.7% | -0.87▲ 0% |
EPS Growth % | - | -776.57% | -148.98% | -4.92% | -57.03% | 46.27% | 15.74% | -3.53% |
EPS (Basic) | -0.06 | -0.49 | -1.22 | -1.28 | -2.01 | -1.08 | -0.91 | - |
Diluted Shares Outstanding | 34.17M | 45.72M | 35.65M | 48.22M | 52.23M | 56.37M | 58.62M | 64.32M |
Basic Shares Outstanding | 34.17M | 45.72M | 35.65M | 48.22M | 52.23M | 56.37M | 58.62M | 64.32M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
NNOX Balance Sheet
Nano-X Imaging Ltd. (NNOX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.7M | 9.64M | 219.79M | 94.86M | 82.46M | 88.64M | 78.68M | 51.31M |
Cash & Short-Term Investments | 5K | 8.07M | 213.47M | 88.71M | 77.62M | 82.38M | 73.21M | 45.19M |
Cash Only | 5K | 8.07M | 213.47M | 66.64M | 38.46M | 56.38M | 39.3M | 45.19M |
Short-Term Investments | 0 | 0 | 0 | 22.07M | 39.16M | 26.01M | 33.9M | 0 |
Accounts Receivable | 0 | 0 | 0 | 1.05M | 977K | 1.48M | 1.8M | 1.94M |
Days Sales Outstanding | - | - | - | 294.18 | 41.57 | 54.69 | 58.39 | 54.47 |
Inventory | 0 | 0 | 0 | 3.13M | 2.41M | 2.36M | 1.49M | 2.67M |
Days Inventory Outstanding | - | - | - | 405.57 | 57 | 52.13 | 24.89 | 30.44 |
Other Current Assets | 0 | 0 | 6.33M | 1.97M | 1.45M | 1.14M | 1.35M | 739K |
Total Non-Current Assets | 156K | 2.23M | 16.36M | 268.31M | 171.47M | 130.01M | 131.32M | 124.77M |
Property, Plant & Equipment | 156K | 754K | 15.38M | 39.16M | 44.7M | 46.92M | 49.2M | 50.39M |
Fixed Asset Turnover | - | - | - | 0.03x | 0.19x | 0.21x | 0.23x | 0.25x |
Goodwill | 0 | 0 | 0 | 58.3M | 7.42M | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 101.83M | 91.22M | 80.61M | 70M | 62.04M |
Long-Term Investments | 0 | 145K | 316K | 67.84M | 25.2M | 327K | 337K | 373K |
Other Non-Current Assets | 0 | 1.34M | 661K | 1.18M | 2.93M | 2.16M | 11.79M | 11.98M |
Total Assets | 1.85M▲ 0% | 11.87M▲ 539.9% | 236.15M▲ 1889.3% | 363.17M▲ 53.8% | 253.93M▼ 30.1% | 218.65M▼ 13.9% | 210M▼ 4.0% | 176.09M▲ 0% |
Asset Turnover | - | - | - | 0.00x | 0.03x | 0.05x | 0.05x | 0.06x |
Asset Growth % | - | 539.95% | 1889.29% | 53.79% | -30.08% | -13.9% | -3.95% | -18.53% |
Total Current Liabilities | 8.24M | 20.26M | 4.48M | 52.75M | 17.07M | 15.52M | 13.97M | 12.39M |
Accounts Payable | 82K | 475K | 435K | 3.13M | 3.62M | 3.3M | 2.21M | 1.41M |
Days Payables Outstanding | 855.14 | 3.27K | 763.34 | 406.22 | 85.45 | 73.08 | 36.83 | 29.28 |
Short-Term Debt | 0 | 0 | 519K | 145K | 740K | 3.49M | 3.06M | 4.14M |
Deferred Revenue (Current) | 0 | 1.83M | 0 | 247K | 182K | 543K | 140K | 749K |
Other Current Liabilities | 0 | 0 | 1.08M | 44.73M | 7.55M | 3.41M | 3.85M | 6.56M |
Current Ratio | 0.21x | 0.48x | 49.06x | 1.80x | 4.83x | 5.71x | 5.63x | 4.14x |
Quick Ratio | 0.21x | 0.48x | 49.06x | 1.74x | 4.69x | 5.56x | 5.52x | 3.93x |
Cash Conversion Cycle | - | - | - | 293.54 | 13.12 | 33.73 | 46.45 | 55.64 |
Total Non-Current Liabilities | 82K | 386K | 923K | 18.27M | 12.18M | 7.61M | 6.91M | 6.99M |
Long-Term Debt | 0 | 0 | 0 | 3.8M | 3.48M | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 386K | 923K | 950K | 398K | 4.04M | 3.64M | 14.62M |
Deferred Tax Liabilities | 0 | 0 | 0 | 7.06M | 3.33M | 2.95M | 2.58M | 9.74M |
Other Non-Current Liabilities | 0 | 0 | 0 | 6.05M | 4.57M | 612K | 695K | 961K |
Total Liabilities | 8.24M | 20.65M | 5.4M | 71.02M | 29.25M | 23.13M | 20.88M | 19.38M |
Total Debt | 0 | 526K | 1.44M | 5.77M | 4.62M | 8.4M | 7.45M | 7.88M |
Net Debt | -5K | -7.55M | -212.03M | -60.87M | -33.84M | -47.98M | -31.86M | -37.31M |
Debt / Equity | - | - | 0.01x | 0.02x | 0.02x | 0.04x | 0.04x | 0.05x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.17x |
Net Debt / EBITDA | - | - | - | - | - | - | - | 0.81x |
Interest Coverage | -380.80x | - | - | -213.74x | - | - | - | -379.29x |
Total Equity | -6.38M▲ 0% | -8.78M▼ 37.5% | 230.75M▲ 2728.7% | 292.15M▲ 26.6% | 224.68M▼ 23.1% | 195.51M▼ 13.0% | 189.12M▼ 3.3% | 156.71M▲ 0% |
Equity Growth % | - | -37.5% | 2728.69% | 26.61% | -23.09% | -12.98% | -3.27% | -18.48% |
Book Value per Share | -0.19 | -0.19 | 6.47 | 6.06 | 4.30 | 3.47 | 3.23 | 2.44 |
Total Shareholders' Equity | -6.38M | -8.78M | 230.75M | 292.15M | 224.68M | 195.51M | 189.12M | 156.71M |
Common Stock | 58K | 75K | 131K | 149K | 158K | 165K | 181K | 185K |
Retained Earnings | -18.04M | -40.6M | -84.42M | -146.21M | -251.46M | -320.23M | -373.75M | -415.39M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -83K | 0 | 0 | -607K | -1.97M | -305K | -1K | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NNOX Cash Flow Statement
Nano-X Imaging Ltd. (NNOX) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -3.67M | -5.52M | -21.49M | -38.07M | -43.38M | -44.78M | -36.6M | -42.2M |
Operating CF Margin % | - | - | - | -2919.56% | -505.77% | -452.06% | -324.36% | - |
Operating CF Growth % | - | -50.48% | -288.98% | -77.18% | -13.96% | -3.21% | 18.27% | -55.07% |
Net Income | -1.91M | -22.56M | -43.81M | -61.8M | -105.24M | -60.78M | -53.52M | -55.71M |
Depreciation & Amortization | 35K | 53K | 208K | 2.29M | 11.51M | 11.81M | 11.73M | 11.79M |
Stock-Based Compensation | 115K | 16.25M | 24.78M | 18.81M | 18.62M | 6.84M | 7.26M | 3.69M |
Deferred Taxes | 0 | -16.35M | -25.3M | -116K | -3.73M | -377K | -377K | -390.07K |
Other Non-Cash Items | 185K | 16.35M | 25.3M | -2K | 52.4M | 5.21M | -572K | -355.56K |
Working Capital Changes | -1.91M | 741K | -2.66M | 2.75M | -16.95M | -7.48M | -1.13M | -1.23M |
Change in Receivables | 0 | 0 | 0 | -40K | 74K | -507K | -321K | -450.66K |
Change in Inventory | 0 | 0 | 0 | 864K | 0 | 0 | -277K | -160.75K |
Change in Payables | -134K | 393K | -103K | 1.72M | 469K | -153K | -1.32M | -233.33K |
Cash from Investing | -73K | -125K | -13.94M | -116.32M | 14.61M | 35.43M | -20.05M | 5.48M |
Capital Expenditures | -73K | -125K | -13.94M | -23.16M | -7.17M | -3.3M | -2.77M | -4.51M |
CapEx % of Revenue | - | - | - | 1775.92% | 83.6% | 33.35% | 24.52% | 36.63% |
Acquisitions | 0 | 0 | 0 | -2.86M | 1.01M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | -90.3M | -1.01M | -373K | 46K | 52.43K |
Cash from Financing | 3.68M | 13.86M | 240.99M | 7.38M | 804K | 27.25M | 39.5M | 43.96M |
Debt Issued (Net) | 0 | 0 | 0 | 3.8M | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 2.12M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 0 | -177K | 630K | 3.58M | 804K | 113K | 1.67M | 4K |
Net Change in Cash | -60K▲ 0% | 8.21M▲ 13786.7% | 205.57M▲ 2403.3% | -147.01M▼ 171.5% | -28.24M▲ 80.8% | 17.85M▲ 163.2% | -17.07M▼ 195.7% | 6.99M▲ 0% |
Free Cash Flow | -3.74M▲ 0% | -5.65M▼ 50.9% | -35.42M▼ 527.1% | -61.23M▼ 72.8% | -50.56M▲ 17.4% | -48.08M▲ 4.9% | -39.37M▲ 18.1% | -46.7M▲ 0% |
FCF Margin % | - | - | - | -4695.48% | -589.37% | -485.41% | -348.89% | -379.64% |
FCF Growth % | - | -50.88% | -527.08% | -72.85% | 17.43% | 4.9% | 18.13% | -16.02% |
FCF per Share | -0.11 | -0.12 | -0.99 | -1.27 | -0.97 | -0.85 | -0.67 | -0.73 |
FCF Conversion (FCF/Net Income) | 1.92x | 0.24x | 0.49x | 0.62x | 0.41x | 0.74x | 0.68x | 0.84x |
Interest Paid | 0 | 0 | 0 | 13K | 90K | 149K | 140K | 102K |
Taxes Paid | 0 | 0 | 8K | 7K | 147K | 3K | 53K | 186K |
NNOX Key Ratios
Nano-X Imaging Ltd. (NNOX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | -39.19% | -23.64% | -40.73% | -28.93% | -27.83% | -35.55% |
Return on Invested Capital (ROIC) | - | -2749.77% | -36.94% | -38.99% | -27.75% | -27.93% | -31.96% |
Gross Margin | - | - | -115.95% | -80.21% | -66.55% | -94.03% | -98.83% |
Net Margin | - | - | -4739.11% | -1226.89% | -613.59% | -474.31% | -452.82% |
Debt / Equity | - | 0.01x | 0.02x | 0.02x | 0.04x | 0.04x | 0.05x |
Interest Coverage | - | - | -213.74x | - | - | - | -379.29x |
FCF Conversion | 0.24x | 0.49x | 0.62x | 0.41x | 0.74x | 0.68x | 0.84x |
Revenue Growth | - | - | - | 557.82% | 15.47% | 13.91% | 15.19% |
Related:NNOX Dividend History·NNOX Revenue History·NNOX Price History·NNOX P/E History·NNOX Financial Ratios·NNOX Institutional Holders
NNOX Frequently Asked Questions
Nano-X Imaging Ltd. (NNOX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Nano-X Imaging Ltd. (NNOX) reported $12.3M in revenue for fiscal year 2024.
Nano-X Imaging Ltd. (NNOX) grew revenue by 13.9% over the past year. This is steady growth.
Nano-X Imaging Ltd. (NNOX) reported a net loss of $55.7M for fiscal year 2024.
Dividend & Returns
Nano-X Imaging Ltd. (NNOX) has a return on equity (ROE) of -27.8%. Negative ROE indicates the company is unprofitable.
Nano-X Imaging Ltd. (NNOX) had negative free cash flow of $46.7M in fiscal year 2024, likely due to heavy capital investments.